Gene Expression Analysis of In Vitro Cocultures to Study Interactions between Breast Epithelium and Stroma by Casbas-Hernandez, Patricia et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 520987, 12 pages
doi:10.1155/2011/520987
Review Article
GeneExpression Analysis of InVitro Coculturesto Study
Interactions betweenBreast Epitheliumand Stroma
Patricia Casbas-Hernandez,1 Jodie M. Fleming,2 andMelissaA.Troester3,4
1Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, NC 27599-7255, USA
2Department of Biology, North Carolina Central University, 1801 Fayetteville Street, Durham, NC 27707, USA
3Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill,
135 Dauer Drive, Chapel Hill, NC 27599-74354, USA
4Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7295, USA
Correspondence should be addressed to Melissa A. Troester, troester@email.unc.edu
Received 1 July 2011; Revised 6 September 2011; Accepted 7 September 2011
Academic Editor: George E. Plopper
Copyright © 2011 Patricia Casbas-Hernandez et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The interactions between breast epithelium and stroma are fundamental to normal tissue homeostasis and for tumor initiation
and progression. Gene expression studies of in vitro coculture models demonstrate that in vitro models have relevance for tumor
progression in vivo. For example, stromal gene expression has been shown to vary in association with tumor subtype in vivo,
and analogous in vitro cocultures recapitulate subtype-speciﬁc biological interactions. Cocultures can be used to study cancer
cell interactions with speciﬁc stromal components (e.g., immune cells, ﬁbroblasts, endothelium) and diﬀerent representative cell
lines (e.g., cancer-associated versus normal-associated ﬁbroblasts versus established, immortalized ﬁbroblasts) can help elucidate
the role of stromal variation in tumor phenotypes. Gene expression data can also be combined with cell-based assays to identify
cellular phenotypes associated with gene expression changes. Coculture systems are manipulable systems that can yield important
insights about cell-cell interactions and the cellular phenotypes that occur as tumor and stroma co-evolve.
1. The Tumor Microenvironment:
The Value of StudyingHeterotypic
InteractionsinCancer Biology
While mutations in oncogenes and tumor suppressors cause
neoplastic epithelial cells to lose many of their growth con-
straints, neoplastic cells do not lose their interactions with
the surrounding nonmalignant cells or with the extracellular
architecture[1].Instead,theinteractionswithcellsinthemi-
croenvironment change during cancer progression and can
promote or repress the tumorigenic process [2, 3]. Growth
factors, cytokines, and proteolytic enzymes are upregulated
a n ds e c r e t e d[ 4, 5], giving a histological appearance of
granulation tissue similar to tissue morphology during phys-
iological wound-healing processes. The observation of histo-
logical changes in tumor adjacent tissue led Dvorak to pro-
pose that tumors are “wounds that do not heal” [6]. More
recent experimental and observational studies have expand-
ed on these observations to further suggest that an activated
stroma may be dominant in cancer progression.
Some key evidence for the dominance of stroma comes
from work identifying windows of susceptibility for breast
cancer initiation and progression (e.g., during pregnancy
and postlactational involution). Extracellular matrix (ECM)
function and composition are remodeled during pregnancy
and lactation [7], and these changes along with other
changes in tissue cellular composition appear to contribute
to increased breast cancer progression [8]. Conversely, pro-
gression can be reversed by stromal changes. Tamoxifen, a
drug that primarily targets ER-positive epithelium, induces
changesinmammarystromaleadingtosuppressionoftrans-
formed phenotypes [9], and premalignant breast cancer
cells placed on a reconstituted physiological basement mem-
brane undergo cell growth arrest and form polarized alveolar2 Journal of Biomedicine and Biotechnology
structures as normal epithelial cells would [10]. These obser-
vations illustrate the important role of stromal response in
breast cancer.
In recent years, tissue-level wound and stromal responses
have been more thoroughly characterized using molecular
data [11, 12]. A growing body of gene microarray data
support a role for stromal gene expression in breast cancer
progression (Table 1). Finak et al. analyzed biopsies of can-
cer tissue and nonaﬀected tissue from breast cancer patients.
By laser capture microdissection, they separated the tumor
compartment from the stromal compartment and per-
formed microarrays to identify a prognostic gene set from
tumor stroma that predicted patient survival [13]. Ma et al.
compared gene expression of ductal carcinoma in situ
(DCIS)-associated stroma to stroma from individuals with
invasive disease and showed that the majority of stromal
alterations occur at the DCIS stage [14]. These authors
argued that invasiveness is dependent on the signals the epi-
thelial cells receive from myoepithelial cells, ﬁbroblasts, and
myoﬁbroblasts. Allinen et al. isolated pure stromal cell pop-
ulations from reduction mammoplasties, DCIS, and invasive
breast cancer patients. Analysis of gene expression of these
puriﬁed cell populations revealed widespread molecular
changes in all cell types of the breast cancer stroma [15]. We
and others have shown an activated wound response in the
tumor microenvironment of breast cancer [11, 16].
Signatures of wound response from in vitro [16]o rin
vivo [11, 12] predict breast cancer survival and relapse in
independent datasets. Finally, Beck et al. have studied both
macrophage inﬁltration-associated gene expression [17]a n d
ﬁbromatosis-associated gene expression [18] as predictors
of outcome. These studies cumulatively suggest that tumor
progression occurs due to the concerted action of a variety of
stromal responses.
The stromal responses to a tumor can be collectively re-
ferred to as “the tumor microenvironment.” It includes all
the structures and cells that support the tumor: extracellular
matrix, blood vasculature, inﬂammatory cells, adipocytes,
myoepithelial cell,s and ﬁbroblasts, all of which have been
shown to contribute to cancer development [19]. However,
itis important todistinguish twotypes ofmicroenvironment
based on location: intratumoral microenvironment and ex-
tratumoral microenvironment. Figure 1 shows a schematic
depicting the wide variety of cells that make up intra
and extratumoral microenvironments. The intratumoral mi-
croenvironment is what has classically been referred to as
“microenvironment of the tumor” or “tumor stroma.” It is
physically located within the tumor mass or very directly
adjacent [20]. The majority of in vivo studies of microenvi-
ronment have emphasized this intratumoral microenviron-
ment as shown in Table 1.H o w e v e r ,s o m es t u d i e sh a v ea l s o
examined theextratumoralmicroenvironment,which extends
further around the perimeter of the tumor (from millimeters
to centimeters, depending on the study) and includes all the
histologically benign tissue that surrounds the tumor. This
extratumoral tissue also provides support for and inﬂuences
tumor progression, reﬂecting either a tissue level response
to the tumor or the baseline biological behavior of the
tissue in which the tumor developed [21]. Both intratumoral
and extratumoral microenvironments are related to the
concept of “ﬁeld cancerization,” initially deﬁned as changes
to the epithelium which are found in histologically normal
tissue near the site of tumorigenesis and that could account
for local recurrences [22]. In recent years, the concept of
ﬁeld cancerization has been broadened to include stromal
changes. A review of epithelial-speciﬁc ﬁeld eﬀects has been
presented elsewhere [23], but, in the current review, we are
focusing on intratumoral and extratumoral stromal changes.
Studies of intratumoral and extratumoral stroma in pa-
tient specimens have identiﬁed interesting biological associ-
ations, but it is diﬃcult to evaluate the speciﬁc contributions
of distinct cellular populations in these complex tissues.
Wiseman and Werb [5] concluded a review article in 2002
with an important idea: “if our aim is to ﬁnd cures for dis-
eases that rely on epithelial and stromal crosstalk we must
increase our understanding of how these diﬀerent cell types
c o m m u n i c a t ew i t he a c ho t h e r . ”In vitro cell-cell communi-
cation studies can be integrated with studies from human
tissue and with animal studies to better understand how het-
erotypic communication alters disease. The purpose of this
review is to summarize some earlier work on cancer-stromal
cocultures, focusing on human breast cancer and especially
on studies that evaluated gene expression using whole
genome approaches. We will then brieﬂy review mouse gene
expression studies focused on the microenvironment and
discuss how coculture data and mouse model systems can
translate to insights on in vivo human microenvironments.
2.In Vitro Cocultures as Models to
Study the Microenvironment
Monoculture studies of breast cancer cells have been the
foundation for much of what we understand about molec-
ular mechanisms and molecular signaling in cancer. Early
studies showed that basal-like and luminal breast cancers
had distinct responses to chemotherapeutics [24], and more
recent studies have comprehensively proﬁled many estab-
lished breast cancer cell lines to identify genomic models for
each breast cancer subtype [25]. Pathway focused studies in
monocultures are also common. For example, Hoadley et al.
showed that basal-like breast cancer cell lines are more
sensitive to the combination of carboplatin and cetuximab
in vitro when compared to luminal cancer cell lines, and that
EGFR-signatures have prognostic value when projected onto
tumor datasets [26]. Other studies have identiﬁed p53-
loss or p53-mutation associated signatures that can predict
mutation status and survival in vivo [27, 28]. Studies of
individual cell lines in monoculture have contributed to the
development of new targeted therapies and are proving to
have relevance in vivo. However, gene expression studies of
monocultureexperimentsarenotinformativeformicroenvi-
ronment inﬂuences on progression. Coculture systems have
become important in studying stromal factors.
Drastic changes occur when coculturing epithelium with
diﬀerent cell types. As a clear example, uterine epithelial cells
proliferateinresponsetoestrogenonlywhencoculturedwith
stromal cells, but not when they are in a monoculture [30].Journal of Biomedicine and Biotechnology 3
Table 1: Whole genome microarray studies to investigate breast cancer microenvironments in human tissues.
Authors
[citation] Type of specimen studied Processing of specimen Type of
microenvironment Major ﬁndings
Finak et. al.
(2008) [13]
Fresh, frozen tissue from primary
cancers (53) and adjacent
nonaﬀected tissue (31) from
breast cancer patients
Laser capture
microdissection
of tumor stroma
Intratumoral versus
extratumoral
Stromal derived prognostic
Predictor (SDPP), a gene set that
stratiﬁes patients by disease
outcome. Genes are involved in
immune response, angiogenesis,
and hypoxic response.
Ma et al.
(2009) [14]
Fresh frozen biopsies from
disease-free tissue, DCIS, and
invasive breast cancer (14).
Laser capture
microdissection Intratumoral
Tumor microenvironment
participates in tumorigensis before
tumor cells invade. Invasiveness is
dependent on the signals from
myoepithelial cells, ﬁbroblasts, and
myﬁbroblosts.
Allinen et al.
(2004) [15]
Snap-frozen biopsies from
reduction mammoplasties,
DCIS, and invasive breast cancer.
Isolation of pure cell
populations by diﬀerential
centrifugation
Intratumoral
Widespread genome changes in all
s t r o m a lc e l lt y p e s .G e n e t i c
alterations only occur in epithelial
cancer cells.
Troester et al.
(2009) [11]
Snap-frozen tissue from
histologically normal tissue
adjacent to breast cancer (47)
and reduction mammoplasties
(60).
Whole genome proﬁles
of the tissue Extratumoral
A wound response is activated in
the tumor microenvironment. The
wound response signature predicts
cancer progression.
Chang et al.
(2004) [12],
Chang et al.
(2005) [16]
Isolated ﬁbroblasts from 10
diﬀerent anatomical sites and
tissue from early breast cancer
patients (295)
In vitro response of the
ﬁbroblast populations
to serum
Intratumoral
normal tissue
Identiﬁcation of an in vitro wound
response, enriched in early stage
tumors. High expression of this
signature correlates with worse
overall survival and increased
distant metastasis.
Beck et al.
(2008) [18]
Desmoid ﬁbromatosis and
solitary ﬁbrous tumors. Intratumoral
DTF core gene set (derived mainly
from ﬁbroblasts) is a robust
descriptor of stromal response that
is associated with improved clinical
outcome in public genomic data
from breast cancer patients.
Beck et al.
(2009) [17]
Tenosynovial giant cell tumors
and pigmented villonodular
synovitis
Intratumoral
The CSF1 gene expression signature
(derived mainly from macrophages)
is present in more aggressive
cancers.
Luciani et al.
(2011) [29]
Tissue from primary breast
tumors and reduction
mammoplasties
Isolation of epithelial
and ﬁbroblast cells. Intratumoral
A “ﬁbroblast triggered gene
expression” gene set generated by
coculture of primary breast tumor
cell lines and ﬁbroblasts is enriched
for inﬂammatory signaling, cell
death, and cell proliferation genes.
Predicts survival in independent
datasets.
Other studies have demonstrated that breast cancer cell lines
in the presence of benign mammary epithelial cells have a
moretransformedphenotypethanwhengrowninmonocul-
ture [3]. Thus, coculture systems can be used to better model
keybiologicalbehaviorsofepithelialandtumorcellsadvanc-
ing the complexity of the system by increments, focusing on
one or a small number of particular characteristics of the
tissue (e.g., ﬁbroblast-cancer cell interactions or mechanical
characteristics).
Cocultures grown in 2-dimensions on plastic are by far
the most common type of culture studied by gene expression
analysis. For some characteristics, 3D cocultures may be
preferable, as they allow cells to organize themselves in space
and to mimic tissue structures in vitro [31, 32]. The gene
expression proﬁles of 3D and 2D cultures of the same cell
lines do show diﬀerences [33]. However, 2D cultures are
easier to work with and can provide valuable genomic infor-
mation. A large number of gene expression studies on 2D
cocultures (Table 2) have been reported, demonstrating that
these cocultures can generate important insights. They can
also preserve important physical characteristics. For exam-
ple, ﬁbroblast-to-myoﬁbroblast transdiﬀerentiation can be4 Journal of Biomedicine and Biotechnology
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Figure 1: Intra- and extratumoral microenvironments and cellular components of these compartments. Cell types present in the extratu-
moral and intratumoral microenvironment are similar and include ﬁbroblasts, immune cells, endothelial cells, and mesenchymal stem cells.
Abundance and signaling of these cells vary widely between and within individuals with cancer.
more easily studied on plastic (2D) than in Matrigel due to
physical properties of the culture surface [34]. In both 2D
and 3D cultures, there are a number of variables that play a
roleindeterminingwhatphenotypesareobserved,including
the ratios of diﬀerent cell types (using a convenient prespec-
iﬁed ratio such as 1:1 versus identifying multiple diﬀerent
biologically relevant ratios) [35], the number of cell types
(e.g.,choosingtococultureepithelialcellsonlywithonestro-
mal cell type or combining multiple cell types), mechanical
factors (culture of cells with certain matrices or polymers to
stimulate stiﬀness or other biophysical properties) [36], or
the degree of cell contact (growing cells in direct physical
contact or separating cell types on transwell cultures).
In addition to these variables that can be explicitly con-
trolled, there are some experimental variables that are less
easily manipulated but important to consider in designing a
study. For example, every cell line is unique and shows indi-
vidual characteristics. To make experiments generalizable, it
maybenecessarytousemultiplecelllines(atleast3ormore)
t oe s t a b l i s hr e p r o d u c i b l et r e n d sf o rag i v e nc e l lt y p e( e . g . ,
three cell lines or more may show consistency in luminal
breast cancer behaviors, whereas one cell line alone cannot
establish behavior of the class of luminal cell lines). Also,
changes in the stromal cells over time should be considered.
If using primary rather than established cell lines for stromal
populations, it is important to consider that primary cells,
such as ﬁbroblasts, ultimately undergo senescence. Senescent
ﬁbroblasts create very diﬀerent signaling milieus [43], so
intraindividual variation in a given ﬁbroblast line in culture
(e.g., due to in vitro aging or passage number) should beJournal of Biomedicine and Biotechnology 5
Table 2: Whole genome microarray studies to investigate breast cancer tumor microenvironment in vitro.
Authors
(citation)
Cancer cell lines
used
Stromal cell lines
used
Type of
coculture
Special
separation
techniques
Linked to
human in vivo
data
Major ﬁndings
Rozenchan
et al. (2009)
[37]
MCF10A,
MDA-MB-231
Primary CAFs and
NAFs Transwell No No
Epithelial cell lines upregulate
diﬀerent pathways when cocultured
with the two types of ﬁbroblasts.
MDA-MB-231-CAF cocultures
(CAFs) upregulate β-catenin/TCF
pathway genes; MDA-MB-231-NAF
cocultures downregulate glycolipid
and fatty acid biosynthesis.
MCF10A-CAF cocultures
upregulate stress response genes,
while MCF10A-NAF cocultures
downregulate growth control and
adhesion genes.
Santos et al.
(2011) [38]
MDA-MB-231,
MDA-MB-435,
MCF7
Primary ﬁbroblasts
from positive and
negative LN
Transwell No No
Gene expression changes induced
by coculture with ﬁbroblasts from
positive and negative nodes are
distinct and intrinsic to each tumor
subtype.
Camp et al.
(2010) [35]
MCF7, T47D,
ZR75, Sum102,
Sum149,
HCC1537
Immortalized
reduction
mammary
ﬁbroblasts
Direct
physical
contact and
transwell
Yes Computational
deconvolution
The response to ﬁbroblast coculture
diﬀers between basal-like and
luminal cancer cell lines. The genes
that distinguish basal-like versus
luminal cultures also distinguishes
human tumors. Basal-likes
upregulate interleukins and
chemokines (IL-6, IL-8, CXCL1,
CXCL3, TGF-β) and TWIST and
SOD1. Luminal cells increase stress
response genes.
Buess et al.
(2009) [39]
Hs578T, BT549,
MDA-MB-436,
MDA-MB-231,
HMEC,
SKBR-3, MCF7,
T47D, HMECs
Stromal
ﬁbroblasts: human
dermal ﬁbroblasts,
embryonic lung
ﬁbroblasts, and
breasts ﬁbroblasts
Direct
physical
contact &
transwell
Yes Computational
deconvolution
Interaction between some breast
cancer cells and stromal ﬁbroblasts
induced interferon response. The
presence of this response is
associated with higher risk of tumor
progression.
Buess et al.
(2009) [40]
HMECs, MCF7,
T47D,
MDA-MB-231,
SKBR-3,
Hs578T, BT549
HuVECs and
human dermal
microvascular
endothelial cells
Direct
physical
contact &
transwell
Yes Computational
deconvolution
Induction of an “M-phase cell cycle
genes” in breast cancer cell lines but
not in normal epithelium. Tumors
with this gene signature have
increased metastasis and worse
overall survival. Endothelial cells
induce proliferation in
CD44+/CD24− cancer cells.
Liu et al.
(2011) [41]
Sum159,
Sum149, MCF7
Human bone
marrow-derived
mesenchymal cells
Direct
physical
contact and
transwell
No No
MSCs regulate cancer cell behavior
through their eﬀects on cancer stem
cells. Networks of cytokines (IL-6,
IL-8, CXCL1, CXCL5, and CXCL6
are associated with migration of
cancer cells).
Wadlow et al.
(2009) [42]
Many
commercially
available cancer
cell lines
Many
commercially
available normal
skin and lung
ﬁbroblasts
Direct
physical
contact
No No
Cancer cell proliferation is
modulated both by the cancer cell
and the ﬁbroblasts. Two
functionally distinct pathways
associated with altered proliferation
were identiﬁed, one of which
showed features of activated
mesenchyme.6 Journal of Biomedicine and Biotechnology
considered when interpreting results. If a primary cell line
will be used, variation in patient characteristics should be
considered (i.e., due to collection of cells from diﬀerent
patients with diﬀerent tumor subtypes, ages, and genetic
or environmental exposure history). It is known that cell
lines can persistently harbor changes due to the exposure
history of their donors [44]. Some studies have used hTERT
immortalized cells to create a renewable source of isogenic
cell lines for coculture studies [35, 45], and this has some
advantages for reproducibility. On the other hand, variation
may be of interest itself, such as variation that suggest dif-
ferencesbetweenAfrican-AmericanandCaucasianﬁbroblast
lines [46]. Aligning the strengths and weaknesses of a given
model system with the research question is more important
than perfectly recapitulating the complexities of the tissue.
2.1. Cellular Phenotypes of Epithelial Cells in Coculture: Chan-
ges in Gene Expression. Epithelial gene expression has been
e x a m i n e di nr e l a t i o nt oe x p o s u r et od i ﬀerent cell types such
as ﬁbroblasts, immune cells, and even adipocytes (Table 2).
Fibroblasts are abundant in the extratumoral and intratu-
moral microenvironment and play an essential role in the
maintenance of normal tissue. The activation of ﬁbroblasts
to myoﬁbroblasts creates a sustained ﬁbrosis and wound-
healing response leading to the desmoplastic reaction in ad-
vanced breast carcinomas [21, 47]. Fibroblasts also deposit
the ECM necessary for cells to adhere, and their activation
changes ECM and signaling to alter tumor initiation and
progression [19].
Rozenchan et al. exposed MCF10A, a benign mammary
epithelial cell line and the transformed MDA-MB-231 cell
line to cancer-associated ﬁbroblasts (CAFs) and normal
tissue-associated ﬁbroblasts (NAFs) from the same patient.
Through this indirect coculture, they found many changes in
the gene expression; MDA-MB-231 cells upregulated genes
involved in the β-catenin/TCF pathway probably related to
regulating cell polarity (DDX21 and DICER) while MCF10A
cells induced stress response (S100A9, HSP90B1, and
SPRR3), prosurvival genes when cultured with CAFs. Mean-
while, in culture with NAFs, MDA-MB-231 responded by
downregulating genes associated with glycolipid and fatty
acid biosynthesis (ACSL5 and AGTPAT4), potentially aﬀect-
ing membrane biogenesis, and MCF10A downregulated
genes critical for growth control and adhesion (DDIT4,
CTNND1, and PCDH1) [37]. The inﬂuence of the ﬁbroblast
on breast cancer cell gene expression has also been observed
in cocultures comparing ﬁbroblasts from negative and pos-
itive lymph nodes [38] and in comparing ﬁbroblasts from
diﬀerent anatomical sites and patients [42]. Each of these
studies showed that ﬁbroblasts from diﬀerent sites and pa-
tients had distinct eﬀects on the cancer cells with which they
were cultured in both cell based assays and gene expression.
The ﬁbroblasts from diﬀerent anatomical sites (skin and
lung) induce distinct proliferation eﬀects on breast cancer
cell lines. These eﬀects can be used to segregate these cell
lines on the basis of their tissue of origin [42]. The tran-
scriptional changes induced in breast cancer cell lines when
coculturedwithﬁbroblastsfrompositive andnegativelymph
nodes had some common features. However, the ﬁbroblast
responses were distinct for each breast cancer cell line, sug-
gesting a stromal response intrinsic to breast cancer subtype
[38]. Likewise, in a diﬀerent model system, soluble inter-
actions between basal and luminal cancer cells had distinct
eﬀects on ﬁbroblast gene expression. When in a transwell
coculture system, basal-like breast cancer cells induced the
upregulation of genes such as IL-6, IL-8, CXCL3, TWIST,
and SOD2 in ﬁbroblasts, while luminal breast cancers did
not [35]. These studies echo one another in demonstrating
that both the ﬁbroblasts and the cancer cells inﬂuence the
character of the interaction.
The studies discussed above were conducted using tran-
swells where cells were not in direct contact, but several gene
expression studies have incorporated direct cell-cell contact
with some additional technical or analytical steps. Direct
cell-cell contact can create gene expression proﬁles that are
distinct from those produced through soluble factors alone.
However, methods for separating the cells may aid interpre-
tation of the resulting gene expression proﬁles. For example,
cells can be transfected with a GFP reporter and grown in
coculture with ﬁbroblasts. The GFP-producing cells can then
be isolated using ﬂow cytometry and subsequently analyzed
[48]. Similarly, magnetic beads have been used to separate
cells and demonstrate that tumor ﬁbroblasts support neo-
plastic progression by altering the epigenome of mammary
epithelial cells [49], speciﬁcally increasing hypermethylation
of the CST6 gene. The authors of that study speculated that
thedirectcell-to-cellcontactisinvolvedintheepigeneticcas-
cade that produces long-term silencing of this gene. Others
have performed a variety of cell-sorting methods, ranging
f r o mt h eu s eo fs u r f a c em a r k e r st ol a b e l i n go fc e l l sw i t h
short-livedcelltrackingdyes[35].Thesecellsortingmethods
are proving to be an important tool for deconvoluting coc-
ultures.
Cocultures can also be deconvoluted using computation-
al methods rather than physical cell sorting. Buess et al. de-
scribed a deconvolution method that computationally con-
trols for cellular composition of cocultures. Using this ap-
proach, it was demonstrated that the interaction between
some breast cancer cells and stromal ﬁbroblasts induces an
interferon-response signature which is correlated with sur-
vival [39]. Using the same deconvolution method, Camp
et al. [35] have recently showen that luminal and basal-like
breast cancer cells respond diﬀerently to the coculture with
ﬁbroblasts, but both show substantially altered expression
relative to the monocultures. Furthermore, the direct cocul-
ture of basal-like breast cancer cells and ﬁbroblasts induced
the expression of interleukins and chemokines such as IL-6,
IL-8, CXCL3, TGF-β also TWIST, and SOD1, while luminal
breast cancer cell line cocultures with ﬁbroblasts upregulated
genesinvolvedinstressresponsesuchastheS100AB,S100A9
genes as well as certain transcription factors (FOXP1 and
FOXA2). These cocultures studies raised the hypothesis that
heterotypic interactions are intrinsic to breast cancer sub-
types, and better understanding of cell-cell interactions will
yield important insights relative to treating and clinical
course of these cancer subtypes.Journal of Biomedicine and Biotechnology 7
Other stromal cell types (beyond ﬁbroblasts) have been
less well studied but certainly play a critical role in tumor
microenvironment. The most widely studied are endothelial,
inﬂammatory, and mesenchymal stem cells. For example,
Buess et al. have documented that endothelial cells cocul-
tured with epithelial cells induce M-phase genes in the
CD44+/CD24− epithelial cell population. This “M-phase
cell cycle gene set” consists of 70 genes such as HMGN2,
CDC2, CDKN3, DICER, and so forth and can predict metas-
tasis in vivo. But perhaps more importantly, endothelial coc-
ultures mirrored results with ﬁbroblasts; gene expression
studies showed complex patterns reﬂecting substantial vari-
ation in the abilities of normal and malignant cells to send
and respond to extrinsic signals [40].
Macrophages have been evaluated for their role in tumor
progression using coculture models. For example, Hage-
mann et al. showed that coculture with macrophages in-
creased tumor cell invasiveness through TNF-α dependant
upregulation of matrix metalloproteinases (MMP-2,-3,-7,-9)
[50]. Hou et al. have recently demonstrated that macropha-
ges induce COX-2 expression in breast cancer cells through
IL-1βsignaling[51].Theseobservationsgaingreaterimport-
ance whenthey are designed to conﬁrmin vivo, biology, such
asworkfollowingonrecentstudies[52]showingthattumor-
associated macrophages may enhance metastasis through
the activation of epidermal growth factor receptor signaling
in neoplastic mammary epithelial cells. Continued work in
cocultures with macrophages can elucidate whether these
macrophage-cancer cell associations are subtype speciﬁc, as
many of the markers induced in cancer cells (e.g., EGFR and
COX2) are strongly associated with breast cancer subtype.
A common theme across stromal cell-breast cancer coc-
ultures has been an increase in cytokines and inﬂammatory
cells. These results have been observed for a variety of mes-
enchymal cell types; therefore, it may not be surprising that
similarresponseshavebeenobservedincocultureswithmes-
enchymal stem cells (MSCs). MSCs are important players
in the tumor microenvironment [1], as they migrate and
engraft into the primary tumor site. This was compellingly
demonstrated in a humanized mouse model; tibial injec-
tions of human MSCs induced increased proliferation and
progression of tumor xenografts [41]. These results also
demonstrate that species diﬀerences are important because
t h em o u s em e s e n c h y m a lc e l l si nt h ec o n t r o la n i m a l s( n o
tibial injection) were not capable of promoting progression
as strongly. Complementary in vitro cocultures used in this
study clearly demonstrated a role of CXCL7 and IL-6 sig-
naling in the aggressive, invasive phenotypes induced by
MSCs. Other recent results also have supported the role of
MSCs in promoting a more aggressive phenotype, showing
that, after direct coculture of MDA-MB-231, T47D, and SK-
Br3 with MSCs, the cancer cells upregulate genes such as
SNAIL, TWIST, vimentin, N-cadherin, and so forth, [53].
Similar observations were detected in transwell assays with
SUM149andHMECc ells[54],suggestingthatmanyofthese
signals may be communicated via soluble factors, potentially
including those factors identiﬁed by Liu et al. [41].
An emerging area that will require additional investi-
gation is how microRNAs modify the stromal-epithelial gene
expression patterns. In a recent study, neoplastic epithelial
cells have been directly cocultured with bone marrow stro-
mal cells, and microRNAs were shown to be transported via
gapjunctionsbetweencancercellsandMSCs.ThesemicroR-
NAs led to reduced CXCL12 expression and a decreased
proliferation [55]. Thus, future studies of gene expression
changes in cocultured cells may ﬁnd that microRNAs play
an important role in controlling some of the observed gene
expression proﬁles. The direct cell-cell transport of a critical
mRNA regulators suggests that the complexity of cell-cell
i n t e r a c t i o n sf a re x c e e d sw h a tw eh a v eb e g u nt ou n d e r s t a n d .
However, a growing database of gene expression data from
coculture studies will help to advance our understanding of
the unique cell-cell interactions that inﬂuence cancer pro-
gression.
While invitrococulturesallowcontrolledinvestigationof
signaling pathways and help to reconstruct step by step the
complexity of cancer biology, human tumors in vivo are the
ultimate system of interest. Thus, most studies have tested
their signatures in coculture by linking the gene expression
patterns with published microarray ﬁndings in patients. For
example, the aforementioned “M-phase cell cycle gene set,”
obtained through the coculture of endothelial cells with the
stem cell portion of cancer cell lines, was projected onto
tumor data to demonstrate that this gene set can predict
metastasis in vivo and patient survival [40]. Luciani et al. also
used their in vitro signature of seven independent primary
tumor cell line cocultures with primary ﬁbroblasts to deﬁne
two groups of patients with distinct overall survival rates
[29]. Other approaches include showing that coculture-de-
rived signatures recapitulate established gene expression
classes. For example, a subtype-speciﬁc ﬁbroblast-coculture
signature predicts breast cancer subtype in tumors, demon-
strating that the in vitro signature is relevant in vivo [35].
These in vivo comparisons can also be combined with exper-
imental data that demonstrate function, either in cell-based
assays in vitro or in mouse models.
A next step with important in vivo implications is ex-
tension of cocultures to study responsiveness to cytotoxic
chemotherapeutics. If signatures associated with increased
toxicity were able to predict pathologic response in vivo,
cocultures could help identify pathways that are promising
as biomarkers or targets in neoadjuvant therapies. Given
the wealth of public data from tumors and their adjacent
m i c r o e n v i r o n m e n tt h a th a sa c c r u e di nr e c e n td e c a d e s ,i ti s
becoming increasingly possible to test the relevance of in
vitro gene expression results in patient populations at little
additional cost. These types of analyses could help deﬁne
candidate pathways involved in interactions to those that are
most likely to play an important role in disease progression.
2.2. Conﬁrming Changes in Cellular Phenotypes: Using Cell-
Based Assays to Corroborate Gene Expression Data with Coc-
ultures. Because much of the research on cocultures has fo-
cused on how the stroma modulates invasive potential, cell-
based assays demonstrating changes in migration and an-
chorage-independent growth can help to establish biologic
plausibility. Epithelial cells, in normal physiological condi-
tions, are immobile, attached to a basement membrane, and8 Journal of Biomedicine and Biotechnology
bound to neighboring cells through several types of cell-
junctions. They present apical versus basal polarity- and
these characteristics are essential for them to carry out their
function in vivo [56]. One of the most drastic and visible
changes that epithelial cells can acquire during carcinogen-
esis is the capacity to migrate, a hallmark of cancer [47].
Thus, migration assays in vitro can help assess how gene
expression changes alter the capacity to migrate and invade.
Common migration assays are transwell/Boyden chamber
assaysandscratch/wound-healingassay.TheBoydenchamber
assay allows for paracrine and autocrine communication
because it uses a transwell coculture system in which the cells
share the same medium but cannot physically interact. The
chemotactic cells are placed on the bottom well, and the mi-
grating cells are placed on the top insert. This insert has
pores big enough (usually 8.0μm) to allow cells to migrate
through. The transwell migration assays may or may not
include an extracellular matrix (ECM) layer. If this ECM
layerispresent, theassay models thecapacity ofcellsto break
down ECM and invade, whereas in the absence of ECM, the
migratory capacity alone is investigated. In either case, the
cells migrating to the opposite side of the transwell insert are
ﬁxed, stained, and counted. The wound/scratch assay allows
for paracrine, autocrine, and cell-to-cell communication.
Cells are seeded on the same surface in direct contact, a
scratch is made when cells are nearly conﬂuent, and cells
migrating into the scratch are measured overtime. By label-
ing one cell type with a ﬂuorescent label, it is possible to
identify which of the two cell types are closing the wound.
Many of the stromal cocultures discussed above have
been evaluated for their eﬀects on migration of cancer cells.
For example, focusing on ﬁbroblasts, Potter et al. showed
that tumor stromal cells (compared to normal stromal cells)
caused greater chemotaxis of MDA-MB-231 and that this
eﬀect could be blocked by the addition of a monoclonal
antibody to CCL2 [57]. MCF7s also become more migratory
when cocultured with ﬁbroblasts [58]. Fibroblast popula-
tions isolated from diﬀerent distances relative to a breast tu-
mor had distinct eﬀects on the migratory capacity of MCF7
cells in scratch assays [59]. Similar ﬁndings have been ob-
served for MSCs [60]a n dm a c r o p h a g e s[ 61]. Breast adipo-
cytes are abundant, comprising a major percentage of the
extratumoral microenvironment, and have also been cocul-
tured with breast cancer cells. Adipocytes are challenging to
culture and coculture because they terminally diﬀerentiate
and cannot be propagated to achieve a reproducible cul-
ture system; however, they are proving to have important
implications for cancer progression. Dirat et al. showed that
the estrogen-receptor positive breast cancer cell line ZR75.1,
and the estrogen-receptor negative line SUM159PT, both
increased their invasive capacity after 72 hours in coculture
with mature primary adipocytes [62].
As an epithelial cell becomes more aggressive, it becomes
less dependent on ECM and basement membrane interac-
tions for survival. After coculture with certain types of cells,
benign or malignant epithelial cells can acquire or enhance
their anchorage-independent growth properties. There are
two main types of assays to address anchorage independ-
ent growth, mammosphere, and soft-agar colony formation
assays. In both cases, coculture studies can be designed to
evaluate paracrine, autocrine, and/or cell-to-cell contacts.
In the mammosphere formation assay, cells are cultured in
suspension in a deﬁned growth media [62]. Colonies are al-
lowed to grow for 7–10 days and then analyzed. Only cells
with anchorage-independent growth capacity will grow, so
the number and size of colonies reﬂect acquisition of this
phenotype. In soft-agar colony formation assays, cells are
grown in a gel-like matrix that provides more structure than
asuspensionculture,butthesamephenotypes (colonynum-
ber and size) are assessed after a period of growth, typically
at least two weeks. These assays have been used to conﬁrm
anchorage-independent growth changes in coculture. For
example, breast cancer ﬁbroblasts decreased time required
for MCF7s to form mammospheres and increased the
overall number of spheres relative to cocultures with normal
ﬁbroblasts. Additionally, when MDA-MB-468, a basal-like
breastcancercellline,wascoculturedwithCAFs,thenumber
of soft-agar colonies were higher than when cocultured with
NAFs [63]. MSCs have also been shown to induce mam-
mosphere formation in human mammary epithelial cells
(HMECs), and SUM149 but not in primary inﬂammatory
breast cancer cells (MDA-IBC-3). These eﬀects occurred
though paracrine factors, as conditioned media from the
MSCs had the same eﬀects [54].
By combining the expression data suggesting a certain
phenotypic trait and with cell-based assays, new treatment-
relevant advances are possible. Genome expression data
along with cell-based assays can be used to test targeted per-
turbations (e.g., blocking cytokines or treating with growth
factors such as in [41]) to study how these phenotypes are
regulated. Given that these studies can be done with human
c e l l s ,a n dw i t hc a r e f u lc o n t r o lo fc e l lr a t i o ,c e l lp h y s i c a le n -
vironment, polarity, and so forth, these systems can pro-
vide interesting and important insights about how cancers
become more invasive and aggressive through interactions
with their environments.
3. Mouse Models for Comparative Biology of
Tumor Microenvironment
Given identiﬁcation of novel hypotheses from in vitro cocul-
tures and conﬁrmation of the cellular phenotypes in vitro,a
complete picture of stromal-epithelial interactions requires
linkages with studies in vivo. As described above, public
genomic data can be useful for this purpose, but mouse
models have contributed to our fundamental understanding
of the reciprocal signaling between stroma and epithelial
compartments. No¨ el et al. performed the ﬁrst inoculation
of cocultured ﬁbroblasts and breast cancer cell lines with
matrigel in an athymic mice model. The inoculation of these
cocultures decreased the latency time and enhanced tumor
growth. Both tumor growth and latency time were depen-
dentonthenumberofinoculatedﬁbroblastsinthecoculture
[64]. In another classic example, it was demonstrated that
when nontumorigenic cell lines are introduced into irradiat-
ed cleared fat pads, they form tumors. Conversely, when
introducedintoclearedfatpadsthathavenotbeenirradiatedJournal of Biomedicine and Biotechnology 9
the same tumorigenic cell lines do not form tumors. This
indicates that radiation induces changes in the stromal mi-
croenvironment that contribute to neoplastic progression in
vivo [65]. More recently, Hu et al. have shown that my-
oepithelial cells suppress, while ﬁbroblasts enhance, tumor
progression from DCIS to invasive cancer in a mouse xen-
ograf model [66]. Novel models for combining and human-
izing the microenvironment have also been proposed, in-
cluding a humanized mouse xenograft model into cleared fat
pads[67],andintraductalxenografts,wherehumancelllines
can be injected alone or with stromal components [68]. An
advantage of these models is that some of the innate immune
responses are preserved, as is the systemic circulation and the
three-dimensional structure of the tissue.
Recently, it has also been established that diﬀerent mouse
models can be used to represent the heterogeneity of human
breastcancers[69].Forexample,theC3Tagmiceoverexpress
the SV40Tag transgene in distal mammary ductal epithelium
andterminal ductallobularunits. Thisoverexpressionallows
for a targeted inactivation of two tumor suppressor genes:
p53 and Rb, giving rise to a very predictable onset of tumors
[70]. They most commonly develop tumors with features of
basal-like breast cancer. Thus, these models may be useful
for studying basal-like microenvironments. Future studies
shouldexaminehowmicroenvironmentcharacteristics,such
as obesity or immune cell ablation, inﬂuence the progression
of tumors in some of these model systems, to gain a per-
spective on the role of microenvironment in diﬀerent breast
cancer subtypes. These models, when combined with cocul-
ture-based mechanistic studies, can be a powerful combina-
tion.
4. Limitations andFutureDirections of
the CocultureModels of GeneExpression
In vitro cocultures have led to signiﬁcant advances in our
understanding of heterotypic interactions among diﬀerent
cell types, complementing mouse studies and human in vivo
studies. They provide an easy and controllable technique
to study heterotypic interactions among diﬀerent cell types.
Because stromal interactions have been proven to be key
in the carcinogenesis process, cocultures are important
tools. However, making inferences about the relevance of
coculture ﬁndings to human patients in vivo requires some
assumptions. An important limitation of cocultures is that
the unit of study is often a single pathway or a small num-
ber of pathways in isolation, and typically limited to cancer
cells and one other stromal cell type. Each coculture system
recapitulates some aspect of the whole tissue and the inter-
actions that are occurring in vivo, but given the complexity
of the whole tissue, cocultures cannot fully recapitulate all
dynamics and dimensions of the tissue. Assays and bioin-
formatics methods are available for studying interactions
between two or three cell types, but incorporating more cell
types has not yet been accomplished. In any case, models
with increasing complexity will be needed to advance our
understanding of heterotypic interactions in breast cancer.
Studies focusing on ECM in heterotypic contexts [71], the
role of mechanical forces and the overall 3D architecture
of the tissue [72] will add new biological insights. Some of
these factors can be addressed one by one in monoculture
and coculture experiments, but it may be that the whole
tissue is more than the sum of its parts. Consider for ex-
ample, a model that incorporates a variety of cell types but
does not account properly for biophysical characteristics of
the tissue. Biomechanical features are of established impor-
tance in cancer progression, and nanotechnology tools for
dynamicallyalteringphysicalenvironmentsmayhelpaddress
this [5, 71]. However, our ability to design cocultures de-
pend on the knowledge we have about which factors matter.
Limitations of the cocultures, and areas where they fail to
explain in vivo phenomena will also potentially be inform-
ative.
There is still much to be learned about tumor-stroma
interactions and cocultures will play an essential role in fur-
ther understanding key processes in carcinogenesis. Future
studies using these coculture system should address several
issues, including how the microenvironment of a tumor
responds to hypoxic conditions and how this aﬀects disease
progression. It is established that hypoxia occurs during tu-
mor progression but the stromal-epithelial interactions af-
fected by these conditions are unknown. These cocultures
also aﬀord the possibility of investigating controversial
hypotheses, such as the Warburg eﬀect, which is not easily
studied in solid tumors. As metabolism has gained recogni-
tion as an important driver of cancer progression [47], novel
methods for studying metabolic microenvironments are
needed. Other studies should explore how cells of diﬀerent
origins, epithelial versus mesenchymal, aﬀect tumor initia-
tion and progression. While a variety of mesenchymal cells
appear to induce similar responses in cancer cells, it remains
unknown whether similar responses can also be induced by
dediﬀerentiating epithelial cells. For example, the concept
of epithelial-to mesenchymal transition (EMT) is gaining
strength in the cancer ﬁeld, and if epithelial cells take on
more mesenchymal phenotypes, the inﬂuences on cancer
progression will be important to study. These transient phe-
notypes are challenging or impossible to study in vivo but
could be more readily manipulated in coculture systems.
Finally, while inﬂammatory responses and cytokine milieus
emerge as important biological determinants of basal-like
versus luminal cancer microenvironments, it will be inter-
esting to investigate the eﬀect of diﬀerent inﬂammatory en-
vironments on epithelial cells in the context of a coculture.
Cancer cell responses to inﬂammatory signals have been
studied in monoculture, but adding other cells to the culture
system will improve the in vivo relevance of these ﬁndings.
5. Conclusions
The tissue stroma is crucial for normal organ homeostasis
as well as for tumor initiation and progression. Additionally,
bothintra-andextratumoralmicroenvironmentsplayessen-
tial roles in tumor biology. Thus, improved understanding of
the interactions that take place between epithelial cells and
stromal compartments is critical to advancing our knowl-
edge of human cancer. In vitro c o c u l t u r es y s t e m sa r ec o n -
trollable systems that can be used to study gene expression10 Journal of Biomedicine and Biotechnology
changes and corresponding cellular phenotypes that occur as
tumor and stroma co-evolve. These systems can be used to
deﬁnecriticalfactorsmediating thecommunicationbetween
the cell types. Although cocultures have limitations, the
growing body of gene expression coculture data demon-
strates that these models are generating important insights
in the biology of breast cancer.
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